Myriad Sucks

Discussion in 'Myriad Pharmaceuticals' started by anonymous, Feb 1, 2017 at 2:23 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


  2. anonymous

    anonymous Guest

    Myriad will continue to see losses in their hereditary division because they are not making any adjustments to the market place. There is new competition and less insurance access as time goes on. Myriad continues to manage this division as if they are the only sheriff in town. They keep saying the same story, challenge your customer, build belief, feel, felt, found, and on and on. How are the goals being set when you have a declining revenue stream occurring and yet you are expected to grow from baseline. Less insurance coverage and more competition means less testing through Myriad, PERIOD!!
    A fresh leadership perspective is definitely needed here or it will continue on the same path!!
     
  3. anonymous

    anonymous Guest

    Stock market in at an all time high. Myriad stock value is lower than it was 5 years ago. Company leadership is inept, throw them out.